Table 1. Baseline characteristics of all tested individuals disaggregated by gender identity (MSM and transwomen), Rio de Janeiro, Brazil.
| MSM (n = 756)* | Transwomen (n = 37)* | p-value** | |||||||
|---|---|---|---|---|---|---|---|---|---|
| HIV- | HIV+ | All MSM | HIV- | HIV+ | All transwomen | HIV- vs. HIV+ | MSM vs. transwomen | ||
| Age | <30-year-old | 378 (59.72) | 72 (58.54) | 450 (59.52) | 20 (68.97) | 7 (87.5) | 27 (72.97) | 1.000 | 0.122 |
| > = 30-year-old | 255 (40.28) | 51 (41.46) | 306 (40.48) | 9 (31.03) | 1 (12.5) | 10 (27.03) | |||
| Skin Color | White | 283 (44.71) | 41 (33.33) | 324 (42.86) | 11 (37.93) | 2 (25) | 13 (35.14) | 0.029 | 0.006 |
| Non-white | 349 (55.13) | 82 (66.67) | 431 (57.01) | 16 (55.17) | 6 (75) | 22 (59.46) | |||
| Unknown | 1 (0.16) | 0 (0) | 1 (0.13) | 2 (6.90) | 0 (0) | 2 (5.41) | |||
| Education | High School or Less | 273 (43.13) | 61 (49.59) | 334 (44.18) | 25 (86.21) | 7 (87.5) | 32 (86.49) | 0.325 | <0.001 |
| Some College or Higher | 355 (56.08) | 62 (50.41) | 417 (55.16) | 4 (13.79) | 1 (12.5) | 5 (13.51) | |||
| Unknown | 5 (0.79) | 0 (0) | 5 (0.66) | 0 (0) | 0 (0) | 0 (0) | |||
| Exposure to HIV | Sexual intercourse | 626 (98.89) | 123 (100) | 749 (99.07) | 29 (100) | 8 (100) | 37 (100) | 1.000 | 1.000 |
| Others | 3 (0.47) | 0 (0) | 3 (0.40) | 0 (0) | 0 (0) | 0 (0) | |||
| Unknown | 4 (0.63) | 0 (0) | 4 (0.53) | 0 (0) | 0 (0) | 0 (0) | |||
| STD (12 m Hist.) | No | 567 (89.57) | 105 (85.37) | 672 (88.89) | 24 (82.76) | 5 (62.5) | 29 (78.38) | 0.099 | 0.064 |
| Yes | 66 (10.43) | 18 (14.63) | 84 (11.11) | 5 (17.24) | 3 (37.5) | 8 (21.62) | |||
| Drug use (12 m Hist.) | No | 550 (86.89) | 111 (90.24) | 661 (87.43) | 16 (55.17) | 3 (37.5) | 19 (51.35) | 0.913 | <0.001 |
| Yes | 78 (12.32) | 11 (8.94) | 89 (11.77) | 12 (41.38) | 5 (62.5) | 17 (45.95) | |||
| Unknown | 5 (0.79) | 1 (0.81) | 6 (0.79) | 1 (3.45) | 0 (0) | 1 (2.70) | |||
| History of HIV test | Previously untested | 514 (81.20) | 87 (70.73) | 601 (79.50) | 23 (79.31) | 4 (50) | 27 (72.97) | 0.004 | 0.405 |
| Previously tested | 119 (18.80) | 36 (29.27) | 155 (20.50) | 6 (20.69) | 4 (50) | 10 (27.03) | |||
| Baseline measures*** | Mean CD4 | - | 493.12 450.44; 538.50] | - | - | 490.83 [448.52; 536.41]**** | - | - | 0.691 |
| Mean Viral Load | - | 76645.21 [76103.34; 77189.56] | - | - | 93662.00 [93063.12; 94263.78]**** | - | - | 0.255 | |
* results are shown as: number (% of all MSM or transwomen)
** Fisher’s exact test was used for all categorical variables and Wilcoxon’s for numeric
*** mean [Poisson CI 95%] for baseline CD4 and VL, available only for patients retained in HIV care
**** only 6 HIV+ transwomen individuals were retained in HIV care.